Merck

Keytruda Adjuvant Therapy Study Shows Reduced the Risk of Disease Recurrence or Death by More Than 40 Percent Compared to Placebo in Stage III Melanoma
CP Wire
Sun, 04/15/18 - 01:54 pm
Merck
Keytruda
melanoma
anti-PD-1 immunotherapy
Keytruda Adjuvant Therapy Study Shows Reduced the Risk of Disease Recurrence or Death by More Than 40 Percent Compared to Placebo in Stage III Melanoma
Sun, 04/15/18 - 01:00 pm
Merck
Keytruda
melanoma
With big Keytruda and Opdivo data coming at AACR, analyst hands Merck the early edge
Fierce Pharma
Fri, 04/13/18 - 12:55 pm
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Yervoy
AACR
Merck's stock surges after positive Keytruda trial results
Marketwatch
Mon, 04/9/18 - 09:32 am
Merck
Keytruda
clinical trials
metastatic non-small cell lung cancer
PDUFA test 2
Tue, 04/10/18 - 12:00 am
Incyte's Horrible News Derails a Promising Class of Cancer Drugs
Motley Fool
Fri, 04/6/18 - 07:43 pm
Incyte
Merck
epacadostat
IDO inhibitors
Roche
NewLink Genetics
How a Biotech Bummer Sent Nektar Therapeutics Stock South Today
Motley Fool
Fri, 04/6/18 - 07:41 pm
Nektar Therapeutics
Incyte
Merck
NKTR-214
Bristol-Myers Squibb
Merck gets a lift, Pfizer a ding as analysts assess immuno-oncology, M&A outlook
Fierce Pharma
Fri, 04/6/18 - 11:49 am
Merck
Pfizer
immuno-oncology
M&A
Keytruda
Prevnar
Ibrance
Xeljanz
Xtandi
Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment
Marketwatch
Fri, 04/6/18 - 09:51 am
Incyte
Merck
melanoma
epacadostat
Keytruda
clinical trials
metastatic melanoma
Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices
Drug Channels
Thu, 04/5/18 - 08:59 am
Eli Lilly
Janssen
Merck
drug pricing
drug discounts
Drug companies want Supreme Court to take eye drop dispute
Yahoo/AP
Sat, 03/31/18 - 09:55 am
eye drops
eye health
Supreme Court
Allergan
Bausch & Lomb
Merck
Pfizer
When Will They Learn? 4 Huge Biotech Blowups
Motley Fool
Thu, 03/29/18 - 09:24 pm
biotech
AstraZeneca
ZS-9
drug manufacturing
Alexion
Synageva
Merck
Cubist Pharmaceuticals
AbbVie
Rova-T
Stemcentrx
Preliminary positive results for Phase I - II trial of Tesaro's Zejula with Keytruda in platinum-resistant ovarian cancer (TSRO)
CP Wire
Mon, 03/26/18 - 02:48 pm
Tesaro
Zejula
Merck
Keytruda
platinum-resistant ovarian cancer
niraparib
clinical trials vaccines
Preliminary positive results for Phase I - II trial of Tesaro's Zejula with Keytruda in platinum-resistant ovarian cancer
Mon, 03/26/18 - 02:41 pm
Tesaro
Zejula
Merck
Keytruda
platinum-resistant ovarian cancer
niraparib
clinical trials
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
AstraZeneca owes $192M in royalties from massive Merck deal, selumetinib licensor Array argues
Fierce Pharma
Wed, 03/21/18 - 09:19 am
AstraZeneca
Merck
selumetinib
Array Biopharma
Roche's Tecentriq triumphs in squamous lung cancer. Can it make its mark against Merck?
Fierce Pharma
Tue, 03/20/18 - 03:27 pm
Roche
Tecentriq
squamous non-small cell lung cancer
Merck
Keytruda
Massachusetts court - Merck can be sued over generic drug injury
Yahoo/Reuters
Sat, 03/17/18 - 10:03 am
Merck
generics
Massachusetts
Merck's Keytruda shows up its rivals with NICE backing in bladder cancer
Fierce Pharma
Fri, 03/16/18 - 09:18 pm
Merck
Keytruda
NICE
bladder cancer
Big Pharma's winners and losers last year? AbbVie and AstraZeneca up, GSK down
Fierce Pharma
Fri, 03/16/18 - 09:42 am
AbbVie
AstraZeneca
GSK
Sanofi
Merck
Big Pharma

Pages